Advaxis Stock Price - ADXS

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 0.77 ▲ 0.00 (0.39%)
Company Name Stock Ticker Symbol Market Type
Advaxis Inc ADXS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.137 21.75% 0.767 0.79 0.64 0.64 0.63 19:51:04
Bid Price Ask Price Spread Spread % News
0.77 0.7799 0.01 1.28% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
21,961 16,960,282 $ 0.7269098 $ 12,328,595 5,310,091 0.181 - 10.80
Last Trade Time Type Quantity Stock Price Currency
19:59:47 formt 800 $ 0.77 USD

Advaxis Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 18.95M 24.71M $ -66.52M -19.74 -10.16 20.30M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 9.00 17.80%

more financials information »

Advaxis News

Loading Messages....

Latest ADXS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADXS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.4360.790.4350.595147910,463,1180.33175.92%
1 Month0.320.790.3110.4788968,282,0140.447139.69%
3 Months0.3060.790.2020.37451348,359,1800.461150.65%
6 Months2.662.950.2020.39979594,364,918-1.89-71.17%
1 Year0.401310.800.1810.59696362,818,6740.365791.13%
3 Years8.6010.800.1811.761,445,691-7.83-91.08%
5 Years3.6030.130.1815.631,319,247-2.83-78.69%

Advaxis Description

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.